Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3 vs 9 Doses of Antibiotics in Live Liver Donors
NCT03765645Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Oct 2018
- Primary completion
- Aug 2020
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, double-blind trial of piperacillin + tazobactam in post-operative infection (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Incidence of infective complications at 1 year. Started Oct 2018; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT03765645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765645.